Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
If approved, donanemab would become only the second drug of its kind for Alzheimer’s in the U.S.
If approved, donanemab would become only the second drug of its kind for Alzheimer’s in the U.S.
What's Your Reaction?
